- Laguna, Ariadna
- Peñuelas, Núria
- Gonzalez-Sepulveda, Marta
- Nicolau, Alba
- Arthaud, Sébastien
- Guillard-Sirieix, Camille
- Lorente-Picón, Marina
- Compte, Joan
- Miquel-Rio, Lluís
- Xicoy, Helena
- Liu, Jiong
- Parent, Annabelle
- Cuadros, Thais
- Romero-Giménez, Jordi
- Pujol, Gemma
- Giménez-Llort, Lydia
- Fort, Patrice
- Bortolozzi, Analía
- Carballo-Carbajal, Iria
- Vila, Miquel
One key limitation in developing effective treatments for neurodegenerative diseases is the lack of models accurately mimicking the complex physiopathology of the human disease. Humans accumulate with age the pigment neuromelanin inside neurons that synthesize catecholamines. Neurons reaching the highest neuromelanin levels preferentially degenerate in Parkinson's, Alzheimer's and apparently healthy aging individuals. However, this brain pigment is not taken into consideration in current animal models because common laboratory species, such as rodents, do not produce neuromelanin. Here we generate a tissue-specific transgenic mouse, termed tgNM, that mimics the human age-dependent brain-wide distribution of neuromelanin within catecholaminergic regions, based on the constitutive catecholamine-specific expression of human melanin-producing enzyme tyrosinase. We show that, in parallel to progressive human-like neuromelanin pigmentation, these animals display age-related neuronal dysfunction and degeneration affecting numerous brain circuits and body tissues, linked to motor and non-motor deficits, reminiscent of early neurodegenerative stages. This model could help explore new research avenues in brain aging and neurodegeneration., This research was funded by: Aligning Science Across Parkinson’s through The Michael J. Fox Foundation for Parkinson’s Research, USA (ASAP-020505 to M.V.); The Michael J. Fox Foundation for Parkinson’s Research, USA (MJFF-007184 and MJFF-001059 to M.V.); Ministry of Science and Innovation (MICINN), Spain (PID2022-141700OB-I00, MCIN/AEI/10.13039/501100011033 to A.B. and PID2020-116339RB-I00 to M.V.); EU Joint Program Neurodegenerative Disease Research (JPND), Instituto de Salud Carlos III, EU/Spain (AC20/00121 to MV): La Caixa Bank Foundation, Spain (INPhINIT fellowship, code LCF/BQ/DI18/1166063 to J.C.; Junior Leader Fellowship LCF/BQ/PR19/11700005 to A.L.; Health Research Grant, ID 100010434 under the agreement LCF/PR/HR17/52150003 to MV); Parkinson’s U.K. (to M.V.); Research grants from Association France Parkinson and Fondation Neurodis (to P.F.); China Scholarship Council (CSC; no. 202008620080) to J.L.; Ministry of Economy and competitiveness (MINECO), Spain with co-funding from FEDER (E.U.) (SAF2015-73997-JIN to A.L.); Ministry of Economy and competitiveness (MINECO), Spain (BES-2017-080191 to N.P.). We are grateful to: the Neurological Tissue Bank of the Biobanc-Hospital Clinic-IDIBAPS (Barcelona, Spain) and the Biobanco en Red de la Región de Murcia-BIOBANC-MUR (Murcia, Spain) for human sample procurement; Sandra Lope-Piedrafita (UAB, Barcelona, Spain) for technical assistance in the performance of MRI experiments in rodents; the Mesoscopic Imaging Facility (MIF) at the European Molecular Biology Laboratory (EMBL) (Barcelona) for support in brain clarification procedures; Sandra Mancilla from the Unit 20 of CIBER in Bioengineering, Biomaterials & Nanomedicne (CIBER-BBN) at VHIR (Barcelona, Spain) and Beatriz Rodríguez-Galván (VHIR) for assistance in histological processing; Ignasi Sahún from the Phenotyping Unit at Parc Científic de Barcelona (Barcelona, Spain), Guillem Colell and Anna Pujol from the Laboratory Animal Service at VHIR, Lidia Castillo-Mariqueo and Daniela Marin-Pardo from the Translational Behavioral Neuroscience Lab at UAB and Pamela Dominguez at VHIR for assistance in animal behavior; Eliana Markidi for immunoblot analyses and laboratory assistance; Alex Rovira (Neuroradiology section, Vall d’Hebron Hospital, Barcelona, Spain) for providing the human NM-MRI images; Ellen Gelpi (Neurological Tissue Bank, Hospital Clínic-IDIBAPS, Barcelona, Spain & Institute of Neurology, Medical University of Vienna, Austria) for providing the human autopsy images; Dr. Takafumi Hasegawa (Department of Neurology, Tohoku University School of Medicine, Sendai, Japan) for kindly providing the TYR plasmid; Dr. Jin Son and Dr. José López-Barneo from Hospital Virgen del Rocío (Sevilla, Spain) for kindly providing the rat TH promoter plasmid; Prof. Kazumasa Wakamatsu and Prof. Shosuke Ito (Fujita Health University, Aichi, Japan) for kindly donating the 5SCD and 5SCDA standards; Professor Gary Miller (Columbia University, USA) for kindly donating the VMAT2 antibody. All diagrams and schematic experimental plans were created with BioRender.com. For the purpose of open access, the author has applied a CC-BY 4.0 public copyright license to all Author Accepted Manuscripts arising from this submission., Peer reviewed